tiprankstipranks
Trending News
More News >
Ascelia Pharma AB (SE:ACE)
:ACE
Sweden Market

Ascelia Pharma AB (ACE) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Ascelia Pharma AB’s (ACE) Moving Averages Convergence Divergence (MACD) indicator is 0.28, suggesting Ascelia Pharma AB is a Buy.
Ascelia Pharma AB’s (ACE) 20-Day exponential moving average is 4.32, while Ascelia Pharma AB’s (ACE) share price is kr4.42, making it a Buy.
Ascelia Pharma AB’s (ACE) 50-Day exponential moving average is 3.86, while Ascelia Pharma AB’s (ACE) share price is kr4.42, making it a Buy.

Ascelia Pharma AB (ACE) Pivot Points

Jun 17, 2025, 12:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.38
4.48
4.53
4.63
4.68
4.78
4.83
Fibonacci
4.48
4.54
4.57
4.63
4.69
4.72
4.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascelia Pharma AB (ACE) Moving Averages

Jun 17, 2025, 12:46 PM
Period
Simple
Exponential
MA5
4.65Sell
4.56Sell
MA10
4.53Sell
4.52Sell
MA20
4.32Buy
4.32Buy
MA50
3.62Buy
3.86Buy
MA100
3.35Buy
3.54Buy
MA200
2.97Buy
3.33Buy
Ascelia Pharma AB’s (ACE) 10-Day exponential moving average is 4.52, while Ascelia Pharma AB’s (ACE) share price is kr4.42, making it a Sell.
Ascelia Pharma AB’s (ACE) 100-Day exponential moving average is 3.54, while Ascelia Pharma AB’s (ACE) share price is kr4.42, making it a Buy.
Ascelia Pharma AB’s (ACE) stock price is kr4.42 and Ascelia Pharma AB’s (ACE) 50-day simple moving average is 3.62, creating a Buy signal.
Ascelia Pharma AB’s (ACE) stock price is kr4.42 and Ascelia Pharma AB’s (ACE) 100-day simple moving average is 3.35, creating a Buy signal.
Ascelia Pharma AB’s (ACE) stock price is kr4.42 and Ascelia Pharma AB’s (ACE) 200-day simple moving average is 2.97, creating a Buy signal.

Ascelia Pharma AB (ACE) Technical Indicators

Jun 17, 2025, 12:46 PM
Name
Value
Implied Action
RSI (14)
56.91
Neutral
STOCH (9,6)
49.26
Neutral
STOCHRSI (14)
54.33
Neutral
MACD (12,26)
0.28
Buy
ADX (14)
34.98
Neutral
Williams %R
-58.50
Buy
CCI (14)
32.14
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
47.84
Neutral
ROC
4.62
Buy
Ascelia Pharma AB’s (ACE) Relative Strength Index (RSI) is 56.91, creating a Neutral signal.
Ascelia Pharma AB’s (ACE) Trend Strength Indicator (ADX) is 34.98, creating a Neutral signal.
Ascelia Pharma AB’s (ACE) Commodity Channel Index (CCI) is 32.14, creating a Neutral signal.
Ascelia Pharma AB’s (ACE) Price Rate of Change (ROC) is 4.62, creating a Buy signal.

FAQ

Is ACE a Buy, Hold, or Sell?
Based on ACE’s technical indicators, ACE is a Buy.
    What is ACE’s RSI (14)?
    ACE’s RSI (14) is 56.91, which suggests ACE is a Neutral.
      What is ACE’s MACD?
      ACE’s MACD is 0.28, which suggests ACE is a Buy.
        What is ACE’s 5-day moving average?
        ACE’s 5-day moving average is 4.65, which suggests ACE is a Sell.
          What is ACE’s 20-day moving average?
          ACE 20-day moving average is 4.32, which suggests ACE is a Buy.
            What is ACE’s 50-day moving average?
            ACE’s 50-day moving average is 3.62, which suggests ACE is a Buy.
              What is ACE’s 200-day moving average?
              ACE’s 200-day moving average is 2.97, which suggests ACE is a Buy.
                What is ACE’s Williams % R (14)?
                ACE’s Williams % R (14) is -58.50, which suggests ACE is a Buy.
                  What is ACE’s CCI (14)?
                  ACE’s CCI (14) is 32.14, which suggests ACE is a Neutral.
                    What is the share price of Ascelia Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis